DANDEKAR ATUL (CSBO) sold 16.6% of their position (6.43K shares) of MAZE THERAPEUTICS, INC. on the open market
Open‑market sale worth $168.8K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 9/4/2026ACC: 0002050167-26-000027
Officer· CSBO
Since Feb 2026
-6.43K
Net shares
Net seller
$168.8K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
6.43K disposed
Non-Derivative Transactions4
Common Stock
Direct
Shares
−2.80K
Price / share
$26.38
Trade value
$73.85K
% of position
7.2%
9/2/2026
38.75K→35.95K
Common Stock
Direct
Shares
−391.00
Price / share
$27.12
Trade value
$10.60K
% of position
1.1%
9/2/2026
35.95K→35.56K
Common Stock
Direct
Shares
−3.21K
Price / share
$26.01
Trade value
$83.42K
% of position
9.0%
9/3/2026
35.56K→32.35K
Common Stock
Direct
Shares
−36.00
Price / share
$25.81
Trade value
$929.16
% of position
0.1%
9/3/2026
32.35K→32.32K
Total
Net shares
−6.43K
Net value
-$168.81K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/2/2026 | S · Sale | −2.80K | $26.38 | $73.85K | 7.2% | 38.75K | 35.95K |
| Common Stock Direct | 9/2/2026 | S · Sale | −391.00 | $27.12 | $10.60K | 1.1% | 35.95K | 35.56K |
| Common Stock Direct | 9/3/2026 | S · Sale | −3.21K | $26.01 | $83.42K | 9.0% | 35.56K | 32.35K |
| Common Stock Direct | 9/3/2026 | S · Sale | −36.00 | $25.81 | $929.16 | 0.1% | 32.35K | 32.32K |
| Total | −6.43K | -$168.81K | ||||||
Derivative Transactions0
No derivative transactions reported